← Back to Treatments
🏅 FDA Orphan Designation

Tryngolza

olezarsen

Manufacturer: Ionis Pharmaceuticals

Indicated for:
Familial chylomicronemia syndromeOrphan

FDA-Approved Indications (1)

adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS)

Indications & Usage

1 INDICATIONS AND USAGE TRYNGOLZA is indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). TRYNGOLZA is an APOC-III -directed antisense oligonucleotide (ASO) indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome (FCS). ( 1 )

💙 Support Programs

View all →
Tryngolza
Ionis Pharmaceuticals

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.